A number of directly acting carcinogenic A'-nitroso compounds were administered to female F344 rats intravesically, to assess their ability to induce tumors locally in the urinary bladder and systemkally following absorption through the bladder mucosa. The compounds were alkylnitosoureas and alkylnitrosocarbamates and could be formed by interaction of amides with bacterially produced nitrite in infected bladders. Methylnhrosourethane was very toxic: doses of 1-2 mg caused death of some rats. A total dose of 0.15 nimol of ethylnitrosourethane, which was much less toxic, was administered to each rat and almost all developed bladder tumors. Ethylnitrosourea also gave rise to bladder tumors following intravesical treatment, and induced some tumors systemkally, whereas methylnitrosourea, 2-methoxyethylnitrosourea and 2-hydroxypropylnitrosourea induced bladder tumors in high incidence and few tumors systemically. Nitrosooxazolidone was quite toxic and induced few bladder tumors. The dialkylnitrosoureas were more stable and some induced more tumors systemically than the monoalkylnitrosoureas. 1,3-Dimethylnitrosourea induced no bladder tumors and 1,3-diethylnitrosourea very few, but both induced tumors systemically that were similar to those induced by gavage treatment of rats. l-Ethyl-l-nitroso-3-hydroxyethylurea, l-hydroxyethyl-l-nhroso-3-ethyhirea and l-(2-hydroxypropyI)-l-nitroso-3-(2-chloroethyr)-urea induced bladder tumors in a majority of rats treated intravesically; the first induced many tumors systemically. Most of the bladder tumors were transitional cell papillomas and carcinomas, but there were a few squamous cell tumors, smooth muscle tumors, sarcomas and carcinosarcomas. The effects of intravesical administration of the directly acting alkylating compounds are compared with the effects of similar doses given to rats by gavage.
Introduction
In a previous report (1) we described the indirect (systemic) carcinogenic effects of some nitrosamines given to rats by intravesicular administration [injection into the urinary bladder, as described by Hashimoto et al. (2) ]. This was in connection with the possibility that nitrosation of amines in urine with nitrite produced by bacterial reduction of nitrate (3) could form A'-nitroso compounds which, by absorption, could have a carcinogenic effect in distant organs. Only 6 of the 15 compounds induced urinary bladder cancer-presumably because of the lack of appropriate enzymes for activating most of them in the bladder mucosa-but almost all of them produced tumors in distant organs, usually according to known target-organ specificity (4) . It is believed that formation of an alkylating intermediate from nitrosamines by metabolism in the target organ is responsible for the later appearance of tumors.
To circumvent the problem posed by the absence of activating enzymes in a particular type of cell, tumors have been induced in some instances by local contact with a directly acting alkylating A'-nitroso compound, such as an alkylnitrosourea or alkylnitrosoguanidine. Thus, colon tumors and urinary bladder tumors have been induced by direct application of solutions of methylnitrosourea through the anus or into the bladder (5-7), whereas nitrosodimethylamine and most other methylnitrosoalkylamines did not induce tumors of the colon or bladder when given orally, by i.p. or i.v. injection, or by inhalation. This suggests that directly acting alkylnitroso compounds, if formed in the urinary bladder or gastrointestinal tract from nitrites and the appropriate amino compound, could contribute to the formation of cancer in those organs in humans. However, it is also of interest whether such endogenously formed, directly acting A'-nitroso compounds could give rise systemically to tumors of internal organs, distant from the site of formation and exposure.
Therefore, a number of directly acting A'-nitroso compounds that had been shown to induce tumors of various organs by oral administration were administered intravesically to groups of female rats in multiple applications, and the types of tumor induced are presented here. Of course, the induction of tumors in die bladder by alkylating agents is likely to be entirely different in mechanism from that proposed for non-mutagenic agents such as saccharin (8) and A'-nitrosodiphenylamine (9) .
The compounds examined included methylnitrosourethane, ethylnitrosourethane and nitrosooxazolidone. These alkylnitrosocarbamate esters are analogs of the A'-nitroso derivatives of many widely used insecticides (10) , which have induced only tumors of die forestomach when given orally to rats (11) . Several directly acting A'-nitroso compounds studied were alkylnitrosoureas, which are unstable in aqueous solution (12) , and the more stable dialkylnitrosoureas, which induce tumors in a wide spectrum of organs when given orally to rats (4), though limited in activity in Syrian hamster organs (13) . Methylnitrosourea and ethylnitrosourea are die two alkylnitrosoureas that have been studied most intensely in rats as models (14, 15) , to elucidate the mechanisms by which alkylating agents induce cancer. The analogous dialkylnitrosoureas, which have half-lives at pH 7 in water of several days, were-1,3-dimethylnitrosourea and 1,3-diediylnitrosourea, both of which have produced similar tumor responses to the monoalkylnitrosoureas when given to rats by gavage or in drinking water.
The other compounds studied were 2-methoxyetiiylnitrosourea, the methyl ether of hydroxyethylnitrosourea, 2-hydroxypropylnitrosourea, l-euiylnitroso-3-hydroxyethylurea, its isomer l-hydroxyethylnitroso-3-ethylurea, and l-(2-hydroxypropyl)-nitroso-3-chloroethylurea. These three asymmetric dialkylnitrosoureas have given rise to small incidences of bladder tumors in rats by oral administration (16) .
Materials and methods

Chemicals
The preparation and characterization of all of the compounds used (Figure 1 ) has been described in previous reports (17) (18) (19) (20) (21) (22) . All were at least 98% pure, as determined by NMR spectroscopy. Although unstable in water, they were stable in absolute ethanol and, for administration to animals, a stock solution in ethanol was diluted with sterile water in the ratio of 3:1 water/ethanol, just prior to treatment.
Animal treatments
Groups of 12 female F344 rats of the colony of the Frederick Cancer Research Facility, born and bred within a barrier, were housed four to a plastic cage and were given Purina Autoclavable Rodent Chow and water ad libitum. Twice a week, with a 3 day interval, the urine was expressed from the bladder of each rat (beginning at 10 weeks of age) under light metophane anesthesia, and 0.2 ml of the 25% ethanol solution of one of the JV-njtroso compounds was injected into the bladder through the urethra.
The doses used for intravesicular treatment (Table I) were similar to those equimolar doses used for gavage treatment with the same compounds in earlier experiments. However, in the case of methylnitrosourethane that dose, 1.4 mg, proved very toxic, causing death of three animals after one treatment. After an interval of some weeks the survivors were treated with 0.7 mg, but this caused distress to the animals and treatment was stopped; these rats received a total of 2.5 mg of methylnitrosourethane. A new group of rats were given 0.2 ml of solution containing 0.35 mg of methylnitrosourethane, but this too caused distress to the animals and their treatment ceased in the third week, when each animal had received -1.8 mg or 0.015 mmol. A 1.6 mg dose of ethylnitrosourethane was somewhat toxic (though no rats died) but 0.8 mg was well tolerated, and it was possible to administer 22 mg intravesically during 14 weeks (0.15 mmol). Nitrosooxazolidone, a cyclic nhrosocarbamate, was administered at 2.4 mg twice a week for 8 weeks and showed considerable toxicity, causing death of one rat 1102 at week 9. Methylnitrosourea, at the original 1.1 mg dose, also caused some distress and treatment was interrupted after three had been given, though no animal had died. After a 2 week interval, treatment resumed at one half concentration (0.5 mg twice a week) and continued for 17 weeks. Ethylnitrosourea at 2.4 mg twice a week was not noticeably toxic, but distress was apparent at week 14 and treatment ceased; one rat died at week 17. Another group of rats was given a lower dose of ethylnitrosourea, 1.2 mg twice a week, for 20 weeks. Methoxyethylnitrosourea had severe toxic effects and caused death of one rat at week 10; treatment ceased at week 17, and all animals died shortly thereafter. 2-Hydroxvpropylnitrosourea was given for 20 weeks. Treatment with the remaining compounds continued without mishap for the prescribed period of 30 weeks. Control animals were given 0.2 ml of 25% aqueous ethanol twice a week intravesically for 30 weeks. Animals were allowed to die naturally or were killed when moribund. They were dissected and all lesions and major organs were fixed in formalin, embedded in paraffin, sectioned and stained with H&E for histologic examination.
Results
The median survival and pattern of tumors in the rats treated intravesically with the various N-nitroso compounds are shown in Table I . All of the treated rats had greatly reduced survival compared with controls. For comparison, the tumors induced by a similar dose of each compound administered by gavage are listed in Table I , with appropriate references. Following the low doses of methylnitrosourethane several rats died within 3 weeks and there was extensive tissue damage, especially pyelonephritis and inflammation of the bladder epithelium; among the several rats that lived for a year or more only two had transitional cell neoplasms of the bladder, probably because of the exceedingly small dose. In addition one rat had a kidney tubular cell neoplasm and several had alveolar/ bronchiolar adenomas of the lungs. It was possible to administer a considerably larger dose of the less toxic ethylnitrosourethane and this induced transitional cell carcinomas of the bladder in most rats, and lung tumors in two of them. The cyclic nitrosocarbamate nitrosooxazolidone caused many early deaths and extensive toxicity to the urinary tract, with tumors in few survivors, including two transitional cell papillomas of the bladder.
Methylnitrosourea and ethylnitrosourea were much less toxic than the alkylnitrosourethanes when administered intravesically, though there was pyelonephritis from the higher dose of ethylnitrosourea and from methylnitrosourea, but little inflammation of the bladder mucosa. Both alkylnitrosoureas induced bladder tumors in essentially all of the treated rats, most of which were transitional cell carcinomas (Table II) . There were tumors in other organs following ethylnitrosourea treatment (some were probably treatment-related, because they arose in rats that lived only 6 months). Bladder tumors were induced in most of the rats given methoxyethylnitrosourea or 2-hydroxypropylnitrosourea, but there were few tumors outside the bladder.
The fairly stable dimethylnitrosourea and diethylnitrosourea given intravesically were potent carcinogens, but not primarily for the bladder. Dimethylnitrosourea induced mainly astrocytomas of the brain and some kidney mesenchymal tumors, similar to the pattern of tumors induced by orally administered dimethylnitrosourea when drinking water was the vehicle (23) . Diethylnitrosourea induced mainly mammary adenocarcinomas, together with some alveolar/bronchiolar adenomas of the lung, a pattern similar to that produced in female rats by oral administration (23) .
Intravesical administration of the remaining three dialkylnitrosoureas gave rise to a high incidence of bladder tumors, mainly transitional cell neoplasms. Ethylnitrosohydroxyethylurea also induced brain tumors in several animals (three oligodendrogliomas, two gliomas, one astrocytoma) and mammary adeno-carcinomas, while among rats given hydroxyethylnitrosoethylurea, two had carcinomas, two had adenomas and one had a sarcoma of the uterus, in addition to several with endometrial stromal polyps; few rats treated with hydroxypropylnitrosochloroethylurea had tumors outside the bladder. All of these tumors have been well described and are commonly induced in rats by Nnitroso compounds.
Bladder tumors were of several types (Table II) , but principally transitional cell carcinomas and papillomas. In several groups, but most notably in the rats given ethylnitrosourea and methoxyethylnitrosourea, there were also other types of tumors in the bladder, including squamous cell neoplasms, carcinosarcoma, Intraveskular administration of /V-nitroso compounds leiomyosarcoma and fibrosarcoma; several rats had more than one type of tumor in the bladder. A few bladder tumors metastasized to other sites, including lung, pancreas, kidney, lymph nodes and mesentery.
Discussion
The directly acting A'-nitroso compounds administered to female rats intravesically, except dimethylnitrosourea, induced tumors of the bladder in some animals. However, as was the case with intravesically administered nitrosamines (1), which require metabolic activation for expression of their carcinogenic potential, Table I 9 (9) 7(5) 10 (7) 1(0) 6(3) 5(2) 2(0) 9 (4) 10 ( several directly acting N-nitroso compounds were effective also in inducing tumors of distant organs in rats. The powerfully mutagenic alkylating agents methylnitrosourea, ethylnitrosourea, 2-hydroxypropylnitrosourea and methoxyethylnitrosourea induced bladder tumors in almost all treated rats; only ethylnitrosourea gave rise to a few tumors of other organs, though these seemed to be related to the treatment and were seen in abundance in rats treated with this compound by the oral route. The lack of a systemic effect was probably due to the poor stability and high reactivity of these alkylnitrosoureas, which might have been absorbed into the bloodstream through the bladder wall in only very small amounts. By oral administration they induced a variety of tumors, including rapidly fatal thymic lymphomas by 2-hydroxypropylnitrosourea (22) . Methylnitrosourethane was extremely toxic to the bladder and kidneys when given intravesically, as it was by i.v. injection (24) . It is not expected that a dose as low as 2 mg would give rise to any tumors, but there were a few tumors of the lungs (which appear to be extremely sensitive to the carcinogenic action of this compound), one kidney tumor and two bladder tumors. Had administration of higher doses been possible, it is likely that tumors would have appeared in more animals, since alkylnitrosocarbamates are more stable than alkylnitrosoureas (24) . This probability is supported by the high incidence of tumors of the bladder induced by intravesicular administration of ethylnitrosourethane, which is, like all ethylnitroso compounds, less toxic to rats than its methyl homolog (4), allowing administration of a larger dose. Nitrosooxazolidone was quite toxic to the bladder, which limited the dose that could be administered intravesically, and it induced tumors in few rats so treated.
The alkylnitrosocarbamates and alkylnitrosoureas given intravesically have a similar, and mainly local, carcinogenic effect in rats, but there is a large difference between the two classes when given orally. The alkylnitrosoureas induce tumors in a broad range of organs (16, 25) , whereas the alkylnitrosocarbamates only give rise to tumors of the forestomach (17, 19) . Alkylation of DNA in liver and other organs is comparable from orally administered alkylnitrosocarbamates and from the analogous alkylnitrosourea (4, 26) , showing that adequate amounts of the nitroso compound are absorbed from the gastrointestinal tract in both cases. These results suggest that the differences in organ specificity between alkylnitrosoureas and alkylnitrosocarbamates is due to their unique chemical structures (27) , because they give rise directly to the same alkylating diazonium ion.
The activity of the dialkylnitrosoureas given intravesically sheds some light on the importance of particular chemical structures in organ-specific carcinogenesis among the N-nitroso compounds. In contrast to the powerful carcinogenic effect in the bladder of methyl-and ethylnitrosourea, dimethylnitrosourea had no carcinogenic effect and diethylnitrosourea produced only two tumors in the rat bladder when administered intravesically. The dialkylnitrosoureas are, however, much more stable in aqueous solution (12) and probably more of the dose enters the circulation through the bladder wall, so that they induce tumors in target organs specific for their structures, brain for methylnitrosoureas, mammary gland for ethylnitrosoureas (27) , for example.
The asymmetric dialkylnitrosoureas, in contrast, are quite effective in inducing bladder tumors when given intravesically, as well as inducing tumors in distant organs. Since ethylnitrosohydroxyethylurea produced bladder tumors in many animals, but diethylnitrosourea has only a small effect in the rat bladder, the presence of the ethylnitrosourea structure is only a partial explanation. Hydroxyethylnitrosoethylurea and hydroxypropybiitrosochloroethylurea induced high incidences of bladder tumors when applied to the bladder, and smaller incidences when given orally (16) . The systemic effects are reversed by oral treatment, which results in greater numbers of internal tumors than by intravesicular treatment. However, alkylnitrosoureas containing hydroxylated alkyl groups are hydrophilic, and are probably less rapidly absorbed from urine through the bladder wall. This might account for the response of the bladder to these compounds given orally or intravesically. The differing results between these compounds administered intravesically shows that the treatment did not impair the function of the bladder wall of the rats as a barrier, since passage of the compounds was selective.
The same dose rate and a similar total dose of hydroxyethylnitrosoethylurea induced tumors of the liver, lung and brain by gavage, but uterine tumors intravesically. Hydroxypropylnitrosochloroethylurea induced tumors of the liver by gavage, but not by intravesicular treatment. It is not clear why there are large differences in systemic carcinogenesis by the hydroxyalkylnitrosoureas between oral and intravesical treatment, since once they are in the bloodstream it would not seem to matter.
It can be assumed that pharmacokinetics play an important role in mediating these differences, since absorption will be into the hepatic portal venous drainage following gavage, whereas absorption through the bladder will result in dissemination directly into the inferior caval drainage. The rates of decomposition or metabolism may be also important, as they are in the case of nitrosodialkylamines. However, there has been little investigation of the biochemistry of alkylnitrosoureas, because the focus has been almost entirely on the mutagenic activity of these compounds through formation of alkylating moieties that alkylate DNA. All of the compounds reported here are directly acting bacterial mutagens, the hydroxypropyl-and hydroxyethylnitrosoureas being particularly potent, but less so than the alkylnitrosocarbamates (4, 28) . Many compounds forming the same alkylating intermediate (alkyldiazonium ion) have profoundly different carcinogenic effects. The results presented here suggest that exploring the pharmacology of directly acting N-nitroso compounds would be rewarding.
